TXR-311

N/A

Report date: 2023/03/25 23:31:50
NME

Base Information

Drug NameTXR-311
Drug Alias NameTXR-311TXR 311
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLiver Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAria Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesAria Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsLiver Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A